Sugden Mary C, Holness Mark J
Centre for Diabetes and Metabolic Medicine, Institute of Cell and Molecular Science, Bart's and the London, Queen Mary's School of Medicine and Dentistry, London, UK.
Arch Physiol Biochem. 2006 Jul;112(3):139-49. doi: 10.1080/13813450600935263.
The mechanisms that control mammalian pyruvate dehydrogenase complex (PDC) activity include its phosphorylation (inactivation) by a family of pyruvate dehydrogenase kinases (PDKs 1 - 4). Here we review new developments in the regulation of the activities and expression of the PDKs, in particular PDK2 and PDK4, in relation to glucose and lipid homeostasis. This review describes recent advances relating to the acute and long-term modes of regulation of the PDKs, with particular emphasis on the regulatory roles of nuclear receptors including peroxisome proliferator-activated receptor (PPAR) alpha and Liver X receptor (LXR), PPAR gamma coactivator alpha (PGC-1alpha) and insulin, and the impact of changes in PDK activity and expression in glucose and lipid homeostasis. Since PDK4 may assist in lipid clearance when there is an imbalance between lipid delivery and oxidation, it may represent an attractive target for interventions aimed at rectifying abnormal lipid as well as glucose homeostasis in disease states.
控制哺乳动物丙酮酸脱氢酶复合体(PDC)活性的机制包括其被丙酮酸脱氢酶激酶家族(PDK1 - 4)磷酸化(失活)。在此,我们综述了与葡萄糖和脂质稳态相关的PDK,特别是PDK2和PDK4的活性及表达调控方面的新进展。本综述描述了与PDK急性和长期调控模式相关的最新进展,特别强调了核受体的调控作用,包括过氧化物酶体增殖物激活受体(PPAR)α和肝X受体(LXR)、PPARγ共激活因子α(PGC - 1α)和胰岛素,以及PDK活性和表达变化对葡萄糖和脂质稳态的影响。由于当脂质输送与氧化之间失衡时,PDK4可能有助于脂质清除,因此它可能是旨在纠正疾病状态下异常脂质及葡萄糖稳态的干预措施的一个有吸引力的靶点。